PSI
ORMP icon

Pinnacle Summer Investments’s Oramed Pharmaceuticals ORMP Stock Holding History

Pinnacle Summer Investments’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		$0 Buy
+40
New +$303 ﹤0.01% 941

Other funds holding ORMP

TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
GIM
Greylin Investment Management Orange, Virginia $598M AUM 18.59% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
CG
Cutler Group San Francisco, California $307M AUM 45.11% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Pinnacle Summer Investments's ORMP Position: Q4 2015 in Review

Pinnacle Summer Investments opened a new position in Oramed Pharmaceuticals (ORMP) in Q4 2015: 40 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #941 among its holdings.

26 funds tracked by Wall St. Rank hold ORMP as of Q4 2015.

  • Pinnacle Summer Investments held 40 shares of Oramed Pharmaceuticals worth $0 as of Q4 2015.
  • Oramed Pharmaceuticals was a new Pinnacle Summer Investments position in Q4 2015.
  • Oramed Pharmaceuticals made up ﹤0.01% of Pinnacle Summer Investments's portfolio in Q4 2015, its #941 holding.
  • 26 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q4 2015.

Based on Pinnacle Summer Investments's 13F filing for Q4 2015, filed 16 Feb 2016.